Hired & Retired: Taking care of business
The industry plumps for business acumen, as companies seek to turn drug candidates from pipeline prospects to products.
Amid the global pandemic, having a solid grasp on how to raise funds and how to support successful commercialization is more important than ever.
This led to BeiGene, as it looks to expand globally, and Vir Biotechnology, as it looks to commercialize its pipeline, to add expertise to their C-suite and boardroom, respectively.
Beyond this, Vertex took on an experienced industry veteran in cell and gene therapies, as it continues its pivot in that direction, and Cytovance Biologics brought in an old partner of its CEO.
For these appointments and more, click through the slideshow above.
